Advanced search
Publication Cover
Current Medical Research and Opinion Volume 24, 2008 - Issue 4
Submit an article Journal homepage
202
Views
22
CrossRef citations to date
0
Altmetric
Original Article

Economic impact of generic substitution of lamotrigine: projected costs in the US using findings in a Canadian setting

Jacques LeLorierCentre de recherche Centre hospitalier de l’Université de Montréal, QuébecCanada
,
Mei Sheng DuhAnalysis Group, Inc. Boston, MAUSACorrespondence[email protected]
,
Pierre Emmanuel ParadisGroupe d’Analyse Ltée, Montréal, QuébecCanada
,
Dominick Latrémouille-ViauGroupe d’Analyse Ltée, Montréal, QuébecCanada
,
Patrick LefebvreGroupe d’Analyse Ltée, Montréal, QuébecCanada
,
Ranjani ManjunathGlaxoSmithKline Research Triangle Park, NCUSA
&
Odile SheehyCentre de recherche Centre hospitalier de l’Université de Montréal, QuébecCanada
 show all
Pages 1069-1081 | Accepted 06 Feb 2008, Published online: 29 Feb 2008

Citations (22)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Josemir W Sander, Philippe Ryvlin, Hermann Stefan, Daniel R Booth & Jürgen Bauer. (2010) Generic substitution of antiepileptic drugs. Expert Review of Neurotherapeutics 10:12, pages 1887-1898.
Read now
Mei Sheng Duh, Kevin E Cahill, Pierre Emmanuel Paradis, Pierre Y Cremieux & Paul E Greenberg. (2009) The economic implications of generic substitution of antiepileptic drugs: a review of recent evidence. Expert Opinion on Pharmacotherapy 10:14, pages 2317-2328.
Read now
Pierre Emmanuel Paradis, Dominick Latrémouille-Viau, Yuliya Moore, Natalia Mishagina, Marie-Hélène Lafeuille, Patrick Lefebvre, Maren Gaudig & Mei Sheng Duh. (2009) Projected economic impact of clinical findings of generic entry of topiramate on G4 European countries. Current Medical Research and Opinion 25:7, pages 1793-1805.
Read now

Articles from other publishers (19)

Martin Holtkamp & William H. Theodore. (2018) Generic antiepileptic drugs-Safe or harmful in patients with epilepsy?. Epilepsia 59:7, pages 1273-1281.
Crossref
H. Gothe, I. Schall, K. Saverno, M. Mitrovic, A. Luzak, D. Brixner & U. Siebert. (2015) The Impact of Generic Substitution on Health and Economic Outcomes: A Systematic Review. Applied Health Economics and Health Policy 13:S1, pages 21-33.
Crossref
David P Crabb, Richard A Russell, Rizwan Malik, Nitin Anand, Helen Baker, Trishal Boodhna, Carol Bronze, Simon SM Fung, David F Garway-Heath, Fiona C Glen, Rodolfo Hernández, James F Kirwan, Claire Lemer, Andrew I McNaught & Ananth C Viswanathan. (2014) Frequency of visual field testing when monitoring patients newly diagnosed with glaucoma: mixed methods and modelling. Health Services and Delivery Research 2:27, pages 1-102.
Crossref
Daniel M. Hartung, Luke Middleton, Leanne Svoboda & Jessina C. McGregor. (2012) Generic Substitution of Lamotrigine Among Medicaid Patients with Diverse Indications. CNS Drugs 26:8, pages 707-716.
Crossref
Julie Eve Desmarais, Linda Beauclair & Howard C. Margolese. (2011) Switching from Brand-Name to Generic Psychotropic Medications: A Literature Review. CNS Neuroscience & Therapeutics 17:6, pages 750-760.
Crossref
Benoît Rouleau, Louise Lavoie, Jacinthe Leblanc, Simon Moretti & Chantal Collin. (2011) Reporting of Adverse Drug Reactions by Community Pharmacists: A Qualitative Study in Quebec. Drug Information Journal 45:5, pages 627-639.
Crossref
Sandra L. Helmers, Pierre Emmanuel Paradis, Ranjani Manjunath, Mei Sheng Duh, Marie-Hélène Lafeuille, Dominick Latrémouille-Viau, Patrick Lefebvre & David M. Labiner. (2010) Economic burden associated with the use of generic antiepileptic drugs in the United States. Epilepsy & Behavior 18:4, pages 437-444.
Crossref
D.M. LabinerP.E. ParadisR. ManjunathM.S. DuhM.-H. LafeuilleD. Latrémouille-ViauP. LefebvreS.L. Helmers. (2010) Generic antiepileptic drugs and associated medical resource utilization in the United States. Neurology 74:20, pages 1566-1574.
Crossref
Stephanie J. Phelps. (2010) A Patient's Voice. The Journal of Pediatric Pharmacology and Therapeutics 15:2, pages 66-67.
Crossref
A. Carius & A. Schulze-Bonhage. (2010) Umstellungen zwischen Lamotrigin-Präparaten bei EpilepsiepatientenChanging lamotrigine preparations in epilepsy patients. Der Nervenarzt 81:4, pages 423-434.
Crossref
Pascal Le Corre. (2010) Bio-équivalence et génériques de principes actifs à marge thérapeutique étroite. La Presse Médicale 39:2, pages 169-176.
Crossref
Pamela Mantri. (2009) Generic substitution: Implications for safe medicines management. British Journal of Neuroscience Nursing 5:9, pages 398-400.
Crossref
Barbara J. Zarowitz & Todd Semla. (2009) Avoiding Potential Pitfalls of Generic Substitution. Geriatric Nursing 30:4, pages 260-263.
Crossref
Barry E. Gidal. (2009) Bioequivalence of antiepileptic drugs: How close is close enough?. Current Neurology and Neuroscience Reports 9:4, pages 333-337.
Crossref
M. S. DuhP. E. ParadisD. Latrémouille-ViauP. E. GreenbergS. P. LeeM. B. DurkinG. J. WanM.F.T. RupnowJ. LeLorier. (2009) The risks and costs of multiple-generic substitution of topiramate. Neurology 72:24, pages 2122-2129.
Crossref
Laura Maria de Figueiredo Ferreira Guilhoto, Veriano Alexandre, Heloise Helena Martins, Cristiane Maciel dos Santos, Katia Lin, Arthur Raymundo Chaves Oliveira da Silva, Sueli Mesquita, Alzira Castro, Alice Masuko & Elza Márcia Targas Yacubian. (2009) Há riscos na utilização de diferentes formulações de drogas antiepilépticas? Relato da ABE através de entrevista de pessoas com epilepsia. Journal of Epilepsy and Clinical Neurophysiology 15:1, pages 41-49.
Crossref
Tania Beltran Papsdorf, Elizabeth Ablah, Surya Ram, Toni Sadler & Kore Liow. (2009) Patient perception of generic antiepileptic drugs in the Midwestern United States. Epilepsy & Behavior 14:1, pages 150-153.
Crossref
Barry E. Gidal & Torbjörn Tomson. (2008) Debate: Substitution of generic drugs in epilepsy: Is there cause for concern?. Epilepsia 49, pages 56-62.
Crossref
. (2013) Generic substitution of lamotrigine doesn't pay. PharmacoEconomics & Outcomes News 551:1, pages 6-6.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.